跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Letero - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Letero
Approved
STANDARD
Letero
Hetero Labs Limited (Unit-VI)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e46c25e905edc1cb
Company
Hetero Labs Limited (Unit-VI)
Type
Standard
Approval Details
Approval Id
e46c25e905edc1cb
Drug Approval Philippines Name
Letero
Product Name
Letero
Registration Number
DRP-9863
Brand Name
Letero
Generic Name
Letrozole
Dosage Form
Film-Coated Tablet
Dosage Strength
2.5 mg
Manufacturer
Hetero Labs Limited (Unit-VI)
Importer
Camber Pharmaceuticals, Inc.
Distributor
Camber Pharmaceuticals, Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
30 January 2022
Expiry Date
16 April 2027
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e46c25e905edc1cb
Type
Standard
Back to Philippines FDA Approvals